“The answer lies with a small population of cells that most standard treatments ignore. Cells that don’t just survive chemotherapy and radiation but adapt and return. They’re called cancer stem cells (CSCs), and they may be the single most overlooked driver of relapse, metastasis, and mortality in cancer care today.” (snip)
“Standard treatment protocols target the fast-dividing cancer cells. CSCs are more resistant and behave differently. They can stay dormant to evade detection, pump drugs out of their system, repair their DNA quickly, thrive in hostile, low-oxygen environments and hijack growth signals from the immune system and surrounding tissue. Adding to the problem, some chemotherapy and radiation protocols may actually stimulate CSCs -- making relapse more likely, not less.” (snip)
"CSCs are biologically wired to survive. They rely on powerful signaling pathways that govern cell survival, repair, and replication. …To beat CSCs, we have to interrupt these signals. The good news is: we can [interrupt them] with repurposed drugs and extremely safe compounds that are widely available."
A more practical document for cancer victims is available in the IMA’s free updated Cancer Care Guide that includes a comprehensive list of repurposed drugs and greater details about which combination of these drugs is best tailored for several different types of cancers (i.e., lung, breast, pancreatic, prostate, stage 4 metastatic diseases, etc.):
Review